Latest New Drug Application Stories
HAYWARD, Calif., Jan. 26, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the U.S.
EWING, N.J., Jan. 20, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
IGI Filed Eleven ANDAs in 2014, and IGI Now Has Twenty-Two Applications Pending at the FDA BUENA, N.J., Dec. 23, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
Biohaven filed a pre-IND meeting request with the FDA regarding lead investigational agent BHV-0223, receives written response in lieu of an in-person meeting TORONTO, Dec.
Expects to complete submission in the first half of 2015 DUBLIN, Dec.
IGI Now Has Nineteen Applications Pending at the FDA BUENA, N.J., Dec. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
CORK, Ireland, November 27, 2014 /PRNewswire/ -- Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S.
--Company Plans to Complete a New Human Factor Validation Study and Respond to the CRL in the First Half of Calendar 2015-- ALISO VIEJO, Calif., Nov.
BUENA, N.J., Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
FDA Can Use Existing Authority to Lower Drug Costs for Consumers, Employers and Public Programs Washington D.C.
- The word or words serving to define another word or expression, as in a dictionary entry.